You are here

Article Text

Article menu
Download PDFPDF
Editorial commentary
Classification and stratification of primary progressive aphasia: CSF biomarkers as a useful tool?
  1. Eloi Magnin1,2
  1. 1Department of Neurology, Memory center (CMRR), CHU Besançon, France
  2. 2Clinical Investigation Center CIC-IT 808 INSERM, CHU Besançon, France
  1. Correspondence to Dr Eloi Magnin, Department of Neurology, CMRR, CHU Besançon, 25000 Besançon, France; eloi.magnin{at}laposte.net

https://doi.org/10.1136/jnnp-2012-302534

Statistics from Altmetric.com

    Request Permissions

    If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

    In the paper by Kas et al,1 the authors report a distinct brain perfusion pattern associated with a CSF biomarker profile in a retrospective study on a large cohort of 34 primary progressive aphasia (PPA) patients (see page 695). Their logopenic variant group is, to our knowledge, the largest series of logopenic PPA patients currently described in the literature. PPA subjects with a CSF profile of Alzheimer's disease have left temporoparietal hypoperfusion such as in logopenic variants of PPA, while those with …

    View Full Text

    Footnotes

    • Competing interests None.

    • Provenance and peer review Commissioned; externally peer reviewed.

    Linked Articles